Movement Alert|Insulet Intraday Rise 5.25% in Regular Trading, Q3 Beat and $1 Billion Buyback Support Shares

Market Focus11-05

On November 5, Insulet recorded an Intraday Rise of 5.25% in Regular Trading, trading at $162.22 with turnover of $132 million.

The move followed the company’s latest quarterly report, which showed adjusted EPS of $1.99 versus the $1.59 consensus estimate and revenue of $842.0 million versus the $832.6 million expectation. Adjusted EPS was up from $1.24 a year earlier, while revenue increased from $706.3 million.

Insulet also maintained its full-year adjusted EPS growth outlook of more than 30% and said its board approved a $1 billion share repurchase program, with about $400 million expected to be repurchased in the fourth quarter using existing cash. The combination of an earnings beat, reaffirmed profitability outlook, and new capital return plan provides a clear near-term catalyst for the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment